Marc Cobo
Principal Accounting Officer · BridgeBio Oncology Therapeutics, Inc.
Individual
- 2026
- Oct 5, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Marc Cobo's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Marc Cobo?
Marc Cobo is a corporate insider, tracked as Principal Accounting Officer of BridgeBio Oncology Therapeutics, Inc. (BBOT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Marc Cobo submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
